跳至主要内容
临床试验/NCT00218348
NCT00218348已完成2 期

Pharmacotherapy for Cocaine Dependence - 1

The University of Texas Health Science Center, Houston2 个研究点 分布在 1 个国家目标入组 186 人开始时间: 2003年9月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
186
试验地点
2
主要终点
Substance use and retention

研究概览

简要总结

Dextro-amphetamine sulfate is a central nervous system stimulant that increases the release of the neurotransmitter dopamine in the brain. The purpose of this study is to further examine dose ranges of dextro-amphetamine sulfate as a treatment for cocaine dependence.

详细描述

This randomized, double-blind dose study will compare the effectiveness of three active medication doses of dextro-amphetamine sulfate to placebo in the treatment of cocaine dependence. Participants will be randomly assigned to one of the four following dosages of dextro-amphetamine sulfate: 0 mg, 40 mg, 60 mg, or 80 mg. Participants will undergo a 2-week stabilization period followed by a 25-week study period. The study period will include administration of the stable medication dose for 21 weeks, followed by 1 week of dose reduction, and then 3 weeks without medication. All participants will receive weekly cognitive behavioral therapy and electrocardiograms. Participants will be given the option to participate in a voluntary plasma blood draw during Weeks 4, 8, and 20 and will be scheduled for follow-up assessments at Months 1 and 3 post-treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
25 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • DSM-IV diagnosis of cocaine dependence, as determined by the Structured Clinical Interview for DSM-IV
  • Agreement to use an adequate method of contraception for the duration of the study
  • Electrocardiogram confirmation by a cardiologist
  • Cocaine-positive urine test prior to study entry

排除标准

  • High blood pressure
  • Significant heart disease
  • Clinically significant cardiovascular abnormality
  • Kidney, liver, or gastrointestinal disorder
  • Current Axis I disorder not related to drug use
  • Current dependence on any drug other than nicotine
  • Attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD)
  • On probation or parole for reasons other than those related to drug abuse charges
  • Pregnant or breastfeeding
  • Sought treatment for drug dependence within 3 months prior to study entry
  • Currently taking prescribed medications

结局指标

主要结局

Substance use and retention

次要结局

  • Effectiveness measures, including psycho-social variables, side effects, and self-reported measures

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joy Schmitz

Professor - Psy, Behavioral Science

The University of Texas Health Science Center, Houston

研究点 (2)

Loading locations...

相似试验